Rchr
J-GLOBAL ID:201901012830927097   Update date: Nov. 21, 2024

Sato Yuhki

Sato Yuhki
Affiliation and department:
Research field  (1): Clinical pharmacy
Research theme for competitive and other funds  (8):
  • 2024 - 2027 神経内分泌ペプチドに着目したクロザピン副作用バイオマーカー開発と漢方治療への応用
  • 2019 - 2023 術後疼痛の症状マネジメントに用いる除痛アルゴリズムと評価指標の構築
  • 2018 - 2021 Development to individualization treatment of Kampo medicine for the side effect with the chemotherapy that intended proper use
  • 2016 - 2019 Development of novel biomarker to individual therapy of nausea and vomitting by chemotherapy
  • 2015 - 2018 Relationship between the peripheral neuropathy due to anticancer drugs and vibration sense or nerve conduction velocity in cancer patients
Show all
Papers (76):
  • Koki Kanamaeda, Masayo Hirao-Suzuki, Takanobu Kobayashi, Yuhki Sato, Masahiro Ohara, Shuso Takeda. Long-term estrogen-deprived estrogen receptor α-positive breast cancer cell migration assisted by fatty acid 2-hydroxylase. Journal of biochemistry. 2024
  • Keishi Yamasaki, Masahiro Tokuno, Kenji Tsukigawa, Yuka Nagatsuka, Koji Nishi, Masaki Otagiri, Yuhki Sato. Possible Involvement of Protein Binding Inhibition in Changes in Dexmedetomidine Concentration in Extracorporeal Circuits during Midazolam Use. Biological & pharmaceutical bulletin. 2024. 47. 2. 389-393
  • 岡田 昌浩, 岡崎 和子, 村田 年弘, 杉原 弘記, 村上 史承, 岡本 伸也, 番匠谷 研吾, 神原 弘恵, 竹井 英介, 佐藤 雄己, et al. 予後期間を考慮した薬学的ケアが退院につながった終末期がん患者の1症例. 日本緩和医療薬学雑誌. 2023. 16. 2. 43-46
  • Ayana Michihara, Miyu Hanada, Yuka Nagatsuka (Handa, Takayuki Mizoguchi, Yoshifumi Ohchi, Yuhki Sato. Change of dexmedetomidine and midazolam concentrations by simultaneous injection in an in vitro extracorporeal circuit. Perfusion. 2023
  • Yorinobu Maeda, Honoka Teraoka, Ami Okada, Mirei Yamamoto, Shintaro Natsuyama, Yuhzo Hieda, Yuka Nagatsuka, Yuhki Sato, Takeshi Goromaru, Teruo Murakami. Development and Evaluation of EDTA-Treated Rabbits for Bioavailability Study of Chelating Drugs Using Levofloxacin, Ciprofloxacin, Hemiacetal Ester Prodrugs, and Tetracycline. Pharmaceutics. 2023. 15. 6. 1589-1589
more...
MISC (19):
  • 狩野大樹, 永塚(半田)由佳, 伴さやか, 佐藤雄己. Antifungal susceptibility profiles of two fungemia-causing and one nonpathogenic Starmerella species. 日本細菌学雑誌(Web). 2023. 78. 1
  • 竹中 隆一, 後藤 孝治, 安田 則久, 佐藤 雄己, 坂本 照夫, 重光 修. 集中治療を要する術後患者における消化管ペプチドと消化管機能の関係. 日本集中治療医学会雑誌. 2022. 29. Suppl.1. 676-676
  • 佐藤 雄己, 後藤 孝治. 敗血症モデルラットを用いたデクスメデトミジンの先発医薬品と後発医薬品の生物学的同等性の検討. 診療と新薬. 2022. 59. 10. 637-642
  • 坂居 知憲, 寺田 莉子, 鮫島 未森, 河上 清香, 佐藤 雄己, 亀川 展幸, 竹内 亮太, 堀 均, Alexander Zaboronok, 中井 啓, et al. イオン液体を溶媒としたBoronophenylalanine製剤のin vitroおよびin vivo評価. 日本薬学会年会要旨集. 2022. 142年会. 27PO10-13S
  • 永塚 由佳[半田], 狩野 大樹, 伴 さやか, 佐藤 雄己. カンジダ血症患者の血液由来Candida sorbosivoransの薬剤感受性. 日本薬学会年会要旨集. 2022. 142年会. 28PO4-05
more...
Professional career (1):
  • 博士(薬学) (熊本大学)
Work history (4):
  • 2019/09 - 現在 Fukuyama University Faculty of Pharmacy and Pharmaceutical Sciences
  • 2015/02 - 2019/08 Oita University University Hospital
  • 2005/04 - 2015/01 Oita University University Hospital
  • 2002/04 - 2005/03 Oita University University Hospital
Association Membership(s) (6):
日本集中治療医学会 ,  日本薬物動態学会 ,  日本臨床腫瘍薬学会 ,  MEDICAL AND PHARMACEUTICAL SOCIETY FOR WAKAN-YAKU ,  JAPANESE SOCIETY OF PHARMACEUTICAL HEALTH CARE AND SCIENCES ,  日本病院薬剤師会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page